Immunomodulatory effects of stem cells.

Area of Science:

• Regenerative Medicine
• Immunology
• Stem Cell Biology

Background:

• Adult-derived mesenchymal stem cells (MSCs) are recognized for their multipotent differentiation capacity and immunomodulatory functions.
• Recent research highlights MSCs' ability to suppress immune cell proliferation and promote regulatory T-cells, suggesting therapeutic potential for immune-mediated diseases.

Purpose of the Study:

• To review the immunosuppressive effects of MSCs on various immune cells.
• To explore the mechanisms underlying MSC-mediated immunosuppression.
• To summarize preclinical and clinical studies using MSCs, including those from dental tissues, for therapeutic applications.

Main Methods:

• Review of existing literature on mesenchymal stem cells, focusing on their immunomodulatory properties.
• Analysis of preclinical animal models and human clinical trials involving MSC transplantation.
• Examination of studies investigating dental-derived MSCs for regenerative and immunomodulatory potential.

Main Results:

• MSCs inhibit T-cell proliferation, stimulate T-regulatory cells, and exert immunosuppressive effects on B-cells, NK cells, dendritic cells, and neutrophils.
• Intravenous administration of allogeneic MSCs has suppressed immune reactions in animal models of transplant rejection, autoimmune, and inflammatory diseases.
• Clinical trials show promising outcomes for MSCs in graft-vs.-host disease and autoimmune conditions.

Conclusions:

• Mesenchymal stem cells possess significant immunomodulatory properties applicable to treating immune-mediated diseases and enhancing tissue regeneration.
• Dental-derived MSCs, such as periodontal ligament stem cells, represent a viable alternative source for both tissue engineering and therapeutic immunomodulation.
• Further research is needed to assess the efficacy of allogeneic dental MSCs in periodontal regeneration and modulating alloreactivity in transplantation.